Champions Oncology, Inc.
NASDAQ: CSBR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert Brainin
- Employees
- 210
- Headquarters
- Hackensack, United States
- IPO year
- 2007
- Market cap
- $85.3M
- Website
- https://www.championsoncology.com
Loading CSBR…
Loading profile data…Frequently asked questions about CSBR
What does Champions Oncology, Inc. (CSBR) do?
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates i...
Where does CSBR trade?
Champions Oncology, Inc. (CSBR) trades on the NASDAQ Capital Market.
What sector is CSBR in?
Champions Oncology, Inc. (CSBR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Champions Oncology, Inc.?
Robert Brainin is the chief executive officer of Champions Oncology, Inc. (CSBR).
Where is Champions Oncology, Inc. headquartered?
Champions Oncology, Inc. is headquartered in United States.
Does CSBR pay a dividend?
Champions Oncology, Inc. (CSBR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CSBR go public?
Champions Oncology, Inc. (CSBR) completed its initial public offering in 2007.